MEI Pharma, Inc.·4

Jul 17, 9:36 PM ET

File Justin J. 4

4 · MEI Pharma, Inc. · Filed Jul 17, 2025

Insider Transaction Report

Form 4
Period: 2025-07-15
File Justin J.
DirectorCEO, CFO and Secretary
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-07-15+20,00020,000 total
    Exercise: $3.07From: 2025-07-15Exp: 2035-07-15Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]Customary annual grant to executives of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary